Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course

BACKGROUND: Imatinib mesylate is the gold standard for the treatment of all phases of Philadelphia-positive chronic myeloid leukemia. Patients on imatinib treatment may develop cytopenia due to drug toxicity. This study aimed to determine the types, grades, and time course of cytopenia in CML patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Hematol
Main Authors: McLigeyo, Angela, Rajab, Jamilla, Ezzi, Mohammed, Oyiro, Peter, Bett, Yatich, Odhiambo, Andrew, Ong'ondi, Matilda, Mwanzi, Sitna, Gatua, Mercy, Abinya, NAOthieno-
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7240645/
https://ncbi.nlm.nih.gov/pubmed/32454829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7696204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados